6108 — New Ray Medicine International Holding Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Market Cap
HK$76.90m
Enterprise Value
HK$16.20m
Revenue
HK$93.95m

Annual balance sheet for New Ray Medicine International Holding, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	65.8	150	154	104	64.3
Net Total Accounts Receivable
Net Total Receivables	17	64.4	54	240	241
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	349	484	404	378	328
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.2	31.4	34.4	29.4	30.8
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	650	662	540	492	505
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33.1	19.5	7.85	5.55	27.3
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	44.2	29.5	14.2	11.3	34.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	606	633	526	480	471
Total Liabilities & Shareholders' Equity	650	662	540	492	505
Total Common Shares Outstanding